China Clinical Trial Services Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Clinical trials can be used as a method to study a wide range of interventions, and by a range of individuals or as we keep referring to them – sponsors. Clinical trials can involve investigating new or existing medicines, medical devices and other medical or non-medical interventions. For example, a clinical trial could involve new drugs, medical devices, biologicals, vaccines, surgical and other medical treatments and procedures. Psycho-therapeutic and behavioural therapies help service changes, preventative care strategies and educational interventions are also examples of clinical trials. Researchers might also conduct clinical trials to evaluate diagnostic or screening tests and new ways to detect and treat disease.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Clinical Trial Services market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Clinical Trial Services market. Detailed analysis of key players, along with key growth strategies adopted by Clinical Trial Services industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • IQVIA

    • Medpace Holdings

    • CRL

    • PPD

    • Labcorp

    • Parexel

    • Syneos Health

    • Wuxi Apptec

    • PRA

    • ICON

    By Type:

    • Phase 1

    • Phase 2

    • Phase 3

    By End-User:

    • Cancer

    • Cardiovascular

    • CNS

    • Infectious Diseases

    • Metabolic Diseases

    • Other Diseases

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Clinical Trial Services Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Clinical Trial Services Market Size and Growth Rate of Phase 1 from 2016 to 2027

    • 1.3.2 China Clinical Trial Services Market Size and Growth Rate of Phase 2 from 2016 to 2027

    • 1.3.3 China Clinical Trial Services Market Size and Growth Rate of Phase 3 from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Clinical Trial Services Market Size and Growth Rate of Cancer from 2016 to 2027

    • 1.4.2 China Clinical Trial Services Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • 1.4.3 China Clinical Trial Services Market Size and Growth Rate of CNS from 2016 to 2027

    • 1.4.4 China Clinical Trial Services Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • 1.4.5 China Clinical Trial Services Market Size and Growth Rate of Metabolic Diseases from 2016 to 2027

    • 1.4.6 China Clinical Trial Services Market Size and Growth Rate of Other Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Clinical Trial Services Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Clinical Trial Services by Major Types

    • 3.4.1 Market Size and Growth Rate of Phase 1

    • 3.4.2 Market Size and Growth Rate of Phase 2

    • 3.4.3 Market Size and Growth Rate of Phase 3

    4 Segmentation of Clinical Trial Services Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Clinical Trial Services by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Clinical Trial Services in Cancer

    • 4.4.2 Market Size and Growth Rate of Clinical Trial Services in Cardiovascular

    • 4.4.3 Market Size and Growth Rate of Clinical Trial Services in CNS

    • 4.4.4 Market Size and Growth Rate of Clinical Trial Services in Infectious Diseases

    • 4.4.5 Market Size and Growth Rate of Clinical Trial Services in Metabolic Diseases

    • 4.4.6 Market Size and Growth Rate of Clinical Trial Services in Other Diseases

    5 Market Analysis by Regions

    • 5.1 China Clinical Trial Services Production Analysis by Regions

    • 5.2 China Clinical Trial Services Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Clinical Trial Services Landscape Analysis

    • 6.1 North China Clinical Trial Services Landscape Analysis by Major Types

    • 6.2 North China Clinical Trial Services Landscape Analysis by Major End-Users

    7 Central China Clinical Trial Services Landscape Analysis

    • 7.1 Central China Clinical Trial Services Landscape Analysis by Major Types

    • 7.2 Central China Clinical Trial Services Landscape Analysis by Major End-Users

    8 South China Clinical Trial Services Landscape Analysis

    • 8.1 South China Clinical Trial Services Landscape Analysis by Major Types

    • 8.2 South China Clinical Trial Services Landscape Analysis by Major End-Users

    9 East China Clinical Trial Services Landscape Analysis

    • 9.1 East China Clinical Trial Services Landscape Analysis by Major Types

    • 9.2 East China Clinical Trial Services Landscape Analysis by Major End-Users

    10 Northeast China Clinical Trial Services Landscape Analysis

    • 10.1 Northeast China Clinical Trial Services Landscape Analysis by Major Types

    • 10.2 Northeast China Clinical Trial Services Landscape Analysis by Major End-Users

    11 Southwest China Clinical Trial Services Landscape Analysis

    • 11.1 Southwest China Clinical Trial Services Landscape Analysis by Major Types

    • 11.2 Southwest China Clinical Trial Services Landscape Analysis by Major End-Users

    12 Northwest China Clinical Trial Services Landscape Analysis

    • 12.1 Northwest China Clinical Trial Services Landscape Analysis by Major Types

    • 12.2 Northwest China Clinical Trial Services Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 IQVIA

      • 13.1.1 IQVIA Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Medpace Holdings

      • 13.2.1 Medpace Holdings Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 CRL

      • 13.3.1 CRL Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 PPD

      • 13.4.1 PPD Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Labcorp

      • 13.5.1 Labcorp Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Parexel

      • 13.6.1 Parexel Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Syneos Health

      • 13.7.1 Syneos Health Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Wuxi Apptec

      • 13.8.1 Wuxi Apptec Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 PRA

      • 13.9.1 PRA Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 ICON

      • 13.10.1 ICON Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Clinical Trial Services Market Size and Growth Rate of Phase 1 from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Phase 2 from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Phase 3 from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of CNS from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Metabolic Diseases from 2016 to 2027

    • Figure China Clinical Trial Services Market Size and Growth Rate of Other Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Clinical Trial Services Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Clinical Trial Services Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Clinical Trial Services

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Clinical Trial Services by Different Types from 2016 to 2027

    • Table Consumption Share of Clinical Trial Services by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Phase 1

    • Figure Market Size and Growth Rate of Phase 2

    • Figure Market Size and Growth Rate of Phase 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Clinical Trial Services by Different End-Users from 2016 to 2027

    • Table Consumption Share of Clinical Trial Services by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of CNS

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Metabolic Diseases

    • Figure Market Size and Growth Rate of Other Diseases

    • Table China Clinical Trial Services Production by Regions

    • Table China Clinical Trial Services Production Share by Regions

    • Figure China Clinical Trial Services Production Share by Regions in 2016

    • Figure China Clinical Trial Services Production Share by Regions in 2021

    • Figure China Clinical Trial Services Production Share by Regions in 2027

    • Table China Clinical Trial Services Consumption by Regions

    • Table China Clinical Trial Services Consumption Share by Regions

    • Figure China Clinical Trial Services Consumption Share by Regions in 2016

    • Figure China Clinical Trial Services Consumption Share by Regions in 2021

    • Figure China Clinical Trial Services Consumption Share by Regions in 2027

    • Table North China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table North China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure North China Clinical Trial Services Consumption Share by Types in 2016

    • Figure North China Clinical Trial Services Consumption Share by Types in 2021

    • Figure North China Clinical Trial Services Consumption Share by Types in 2027

    • Table North China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table North China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure North China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure North China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure North China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table Central China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table Central China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure Central China Clinical Trial Services Consumption Share by Types in 2016

    • Figure Central China Clinical Trial Services Consumption Share by Types in 2021

    • Figure Central China Clinical Trial Services Consumption Share by Types in 2027

    • Table Central China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table Central China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure Central China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure Central China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table South China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table South China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure South China Clinical Trial Services Consumption Share by Types in 2016

    • Figure South China Clinical Trial Services Consumption Share by Types in 2021

    • Figure South China Clinical Trial Services Consumption Share by Types in 2027

    • Table South China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table South China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure South China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure South China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure South China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table East China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table East China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure East China Clinical Trial Services Consumption Share by Types in 2016

    • Figure East China Clinical Trial Services Consumption Share by Types in 2021

    • Figure East China Clinical Trial Services Consumption Share by Types in 2027

    • Table East China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table East China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure East China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure East China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure East China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table Northeast China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table Northeast China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Clinical Trial Services Consumption Share by Types in 2016

    • Figure Northeast China Clinical Trial Services Consumption Share by Types in 2021

    • Figure Northeast China Clinical Trial Services Consumption Share by Types in 2027

    • Table Northeast China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table Northeast China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure Northeast China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure Northeast China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table Southwest China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table Southwest China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Clinical Trial Services Consumption Share by Types in 2016

    • Figure Southwest China Clinical Trial Services Consumption Share by Types in 2021

    • Figure Southwest China Clinical Trial Services Consumption Share by Types in 2027

    • Table Southwest China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table Southwest China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure Southwest China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure Southwest China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table Northwest China Clinical Trial Services Consumption by Types from 2016 to 2027

    • Table Northwest China Clinical Trial Services Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Clinical Trial Services Consumption Share by Types in 2016

    • Figure Northwest China Clinical Trial Services Consumption Share by Types in 2021

    • Figure Northwest China Clinical Trial Services Consumption Share by Types in 2027

    • Table Northwest China Clinical Trial Services Consumption by End-Users from 2016 to 2027

    • Table Northwest China Clinical Trial Services Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Clinical Trial Services Consumption Share by End-Users in 2016

    • Figure Northwest China Clinical Trial Services Consumption Share by End-Users in 2021

    • Figure Northwest China Clinical Trial Services Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of IQVIA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IQVIA

    • Figure Sales and Growth Rate Analysis of IQVIA

    • Figure Revenue and Market Share Analysis of IQVIA

    • Table Product and Service Introduction of IQVIA

    • Table Company Profile and Development Status of Medpace Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medpace Holdings

    • Figure Sales and Growth Rate Analysis of Medpace Holdings

    • Figure Revenue and Market Share Analysis of Medpace Holdings

    • Table Product and Service Introduction of Medpace Holdings

    • Table Company Profile and Development Status of CRL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRL

    • Figure Sales and Growth Rate Analysis of CRL

    • Figure Revenue and Market Share Analysis of CRL

    • Table Product and Service Introduction of CRL

    • Table Company Profile and Development Status of PPD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PPD

    • Figure Sales and Growth Rate Analysis of PPD

    • Figure Revenue and Market Share Analysis of PPD

    • Table Product and Service Introduction of PPD

    • Table Company Profile and Development Status of Labcorp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Labcorp

    • Figure Sales and Growth Rate Analysis of Labcorp

    • Figure Revenue and Market Share Analysis of Labcorp

    • Table Product and Service Introduction of Labcorp

    • Table Company Profile and Development Status of Parexel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Parexel

    • Figure Sales and Growth Rate Analysis of Parexel

    • Figure Revenue and Market Share Analysis of Parexel

    • Table Product and Service Introduction of Parexel

    • Table Company Profile and Development Status of Syneos Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Syneos Health

    • Figure Sales and Growth Rate Analysis of Syneos Health

    • Figure Revenue and Market Share Analysis of Syneos Health

    • Table Product and Service Introduction of Syneos Health

    • Table Company Profile and Development Status of Wuxi Apptec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wuxi Apptec

    • Figure Sales and Growth Rate Analysis of Wuxi Apptec

    • Figure Revenue and Market Share Analysis of Wuxi Apptec

    • Table Product and Service Introduction of Wuxi Apptec

    • Table Company Profile and Development Status of PRA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PRA

    • Figure Sales and Growth Rate Analysis of PRA

    • Figure Revenue and Market Share Analysis of PRA

    • Table Product and Service Introduction of PRA

    • Table Company Profile and Development Status of ICON

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICON

    • Figure Sales and Growth Rate Analysis of ICON

    • Figure Revenue and Market Share Analysis of ICON

    • Table Product and Service Introduction of ICON


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.